Elevance Health, Inc. (NYSE:ELV – Get Free Report) was the recipient of a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 3,630,000 ...

After a dip in the wake of the release of UnitedHealth Group's Q4 2024 earnings figures, shares in the company and other ...

Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...

Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's ...

Health insurance provider Elevance Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per ...

Equities research analysts at Zacks Research lowered their Q2 2025 earnings estimates for Elevance Health in a research ...

The Indianapolis-based company said it had net income of $1.81 per share. Earnings, adjusted for one-time gains and costs, came to $3.84 per share. The results beat Wall Street expectations. The ...

A collection of prominent healthcare interests were among the donors to President Donald Trump’s inaugural fund. | The pharma ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $492.5, with a ...

Health-care companies rose sharply amid strong earnings.

Elevance Health Inc. (ELV), while reporting weak fourth-quarter earnings below market estimates, on Thursday issued fiscal 2025 ...

Elevance Health Inc (ELV) stock saw a decline, ending the day at $400.96 which represents a decrease of $-0.40 or -0.10% from the prior close of $401.36. The stock opened at $397.16 and touched a low ...